2.1 Stages of drug discovery and development
3 min read•august 9, 2024
Drug discovery and development is a complex, multi-stage process. It starts with identifying disease targets and screening potential compounds. The most promising leads then undergo rigorous preclinical testing to assess safety and efficacy before moving to human trials.
Clinical trials are the cornerstone of drug development, progressing through three main phases. These trials evaluate safety, efficacy, and optimal dosing in increasingly larger patient populations. Regulatory approval is the final hurdle before a new drug can reach patients.
Drug Discovery
Target Identification and Lead Compound Selection
Top images from around the web for Target Identification and Lead Compound Selection
Frontiers | QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery View original
Is this image relevant?
Frontiers | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD View original
Is this image relevant?
Frontiers | Application of Machine Learning for Drug–Target Interaction Prediction View original
Is this image relevant?
Frontiers | QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery View original
Is this image relevant?
Frontiers | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD View original
Is this image relevant?
1 of 3
Top images from around the web for Target Identification and Lead Compound Selection
Frontiers | QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery View original
Is this image relevant?
Frontiers | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD View original
Is this image relevant?
Frontiers | Application of Machine Learning for Drug–Target Interaction Prediction View original
Is this image relevant?
Frontiers | QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery View original
Is this image relevant?
Frontiers | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD View original
Is this image relevant?
1 of 3
- involves identifying specific molecules (proteins, genes, or RNA) involved in disease processes
- Utilizes various techniques including genomics, proteomics, and bioinformatics to identify potential targets
- tests thousands of compounds against the identified target
- Lead compound emerges as the most promising molecule showing desired effects on the target
- studies optimize lead compounds for improved potency and safety
- techniques modify lead compounds to enhance their drug-like properties (solubility, stability)
Preclinical Studies and Safety Assessment
- In vitro studies evaluate compound's mechanism of action and potential toxicity using cell cultures
- In vivo studies assess drug effects in animal models to determine efficacy and safety profiles
- Pharmacokinetic studies analyze drug absorption, distribution, metabolism, and excretion (ADME)
- determine potential adverse effects and safe dosage ranges
- Formulation development optimizes drug delivery method (oral tablets, injectables, topical creams)
- ensure quality and integrity of preclinical data
Clinical Trials
IND Application and Phase I Trials
- application submitted to FDA for clinical trial approval
- IND includes preclinical data, manufacturing information, and clinical protocols
- assess drug safety and tolerability in healthy volunteers (20-100 participants)
- Determine and in humans
- Evaluate side effects and establish maximum tolerated dose
- Usually conducted in specialized clinical pharmacology units
- Typically last several months and have a single-ascending dose design
Phase II and III Clinical Trials
- evaluate drug efficacy in patients with target disease (100-300 participants)
- Determine optimal dosing regimens and further assess safety profile
- Often include randomized, controlled study designs
- confirm efficacy and monitor long-term safety (1000-3000 participants)
- Compare new drug to current standard treatments or placebos
- Evaluate drug in diverse patient populations and multiple clinical sites
- Generate data on drug interactions and special populations (elderly, children)
- Can last several years and involve complex study designs (double-blind, multi-arm)
Regulatory Approval
NDA Submission and FDA Review Process
- compiles all data from drug discovery through clinical trials
- Includes comprehensive information on drug chemistry, manufacturing, and controls
- Presents detailed analysis of clinical efficacy and safety data
- FDA review teams (medical officers, statisticians, pharmacologists) evaluate NDA
- Advisory committee meetings may be held to discuss complex or controversial applications
- FDA issues Complete Response Letter for applications requiring additional information
FDA Approval and Post-Marketing Surveillance
- grants permission to market the drug for specific indications
- Labeling negotiations finalize prescribing information and patient medication guides
- may be required for drugs with serious safety concerns
- (Phase IV) monitors drug safety in real-world use
- collect data on unexpected side effects
- may be required to address specific safety or efficacy questions
- Periodic safety update reports submitted to
- FDA can require label changes or market withdrawal based on post-marketing data
Key Terms to Review (31)
Adverse Event Reporting Systems: Adverse event reporting systems are structured frameworks for collecting and analyzing information regarding unintended or harmful events that occur during the use of pharmaceuticals, medical devices, or other therapeutic interventions. These systems are critical in ensuring patient safety, as they help identify potential safety issues and facilitate regulatory responses to mitigate risks associated with drugs and devices throughout their lifecycle.
Bioavailability: Bioavailability refers to the proportion of a drug or other substance that enters the circulation when it is introduced into the body and is available for therapeutic effect. This term is crucial in understanding how a drug's formulation, route of administration, and metabolic processes affect its effectiveness. It plays a significant role in the drug development process, influencing dosage forms and treatment protocols throughout the stages of drug discovery and development.
Cost-effectiveness analysis: Cost-effectiveness analysis (CEA) is a method used to compare the relative costs and outcomes of different courses of action, particularly in healthcare. This approach helps decision-makers understand the economic value of various treatments and interventions by calculating the cost per unit of health benefit, such as cost per quality-adjusted life year (QALY). CEA plays a critical role in guiding resource allocation, informing pricing strategies, and assessing the value of new medical innovations.
Dose-Response Relationship: The dose-response relationship describes the correlation between the dose of a drug or chemical and the magnitude of its biological effect. Understanding this relationship is crucial during drug discovery and development, as it helps to establish the therapeutic range, safety, and efficacy of a drug, informing dosage guidelines and potential side effects.
FDA Approval: FDA approval refers to the authorization granted by the U.S. Food and Drug Administration for a drug or medical product to be marketed and sold after it has been proven safe and effective through rigorous testing. This process involves several stages of research, including preclinical testing and clinical trials, which ensure that the product meets safety standards and efficacy requirements before reaching consumers.
Good Laboratory Practices (GLP): Good Laboratory Practices (GLP) are a set of principles intended to ensure the quality and integrity of non-clinical laboratory studies, particularly those conducted for the purpose of regulatory submissions. GLP guidelines help to standardize the conditions under which laboratory studies are conducted, ensuring that data produced is reliable and reproducible. This is crucial in the stages of drug discovery and development, as it ensures that all preclinical data submitted to regulatory authorities meets strict quality standards.
Half-life: Half-life is the time required for the concentration of a drug in the bloodstream to reduce to half its original value. This concept is crucial in understanding how long a drug remains effective and influences dosing schedules, therapeutic levels, and drug accumulation within the body. A drug's half-life can vary greatly depending on factors like metabolism, clearance rates, and the presence of other substances, making it essential in the drug discovery and development process.
High-throughput screening: High-throughput screening is a method used in drug discovery that allows researchers to quickly test thousands of compounds for their biological activity against specific targets. This technology significantly accelerates the drug discovery process by automating the testing of large libraries of chemical compounds, making it easier to identify promising candidates for further development. The efficiency and speed of high-throughput screening have transformed how drugs are discovered, impacting historical development and current market trends in the pharmaceutical industry.
In vitro testing: In vitro testing refers to the process of conducting experiments in a controlled environment outside of a living organism, typically using cells or biological molecules. This method allows researchers to observe biological responses and interactions without the complexities and ethical concerns associated with in vivo studies, which involve live subjects. It's a crucial step in drug discovery and development as it enables the early evaluation of drug efficacy, toxicity, and mechanism of action.
In vivo testing: In vivo testing refers to the process of conducting experiments in a living organism, such as animals or humans, to study the effects of a substance or treatment. This type of testing is crucial in drug development as it allows researchers to observe the biological interactions and efficacy of a drug within the complex systems of a living body, providing insights that cannot be gained through in vitro methods alone.
Investigational New Drug (IND): An Investigational New Drug (IND) is a pharmaceutical product that has been authorized by regulatory authorities to be tested in humans for safety and efficacy before it can receive full approval for marketing. The IND process is a crucial step in drug development, allowing researchers to assess the drug's effects in a controlled environment while also ensuring patient safety. This phase includes preclinical studies, which provide necessary data on the drug's effects, followed by clinical trials that evaluate the drug in human subjects across various phases.
Lead Compound Selection: Lead compound selection is the process of identifying a compound that shows promise as a potential drug candidate, typically based on its biological activity, selectivity, and pharmacokinetic properties. This crucial step in drug discovery helps researchers narrow down numerous candidates to a few that are most likely to succeed in later stages of development. By evaluating the lead compounds, scientists can determine which ones have the best chance to be further developed into safe and effective therapies.
Market Exclusivity: Market exclusivity refers to the period during which a pharmaceutical product is protected from competition, allowing the company that developed it to sell it without generic alternatives. This exclusivity is critical as it provides an incentive for companies to invest in research and development by ensuring that they can recoup their investment without immediate pressure from lower-cost alternatives. Market exclusivity relates to various aspects, such as the stages of drug discovery, strategies for prolonging that exclusivity, innovation incentives impacting affordability, economic factors within the industry, and how these exclusivity periods influence pricing strategies for drugs and devices.
Medicinal Chemistry: Medicinal chemistry is a branch of chemistry that focuses on the design, development, and optimization of pharmaceutical compounds. This field plays a crucial role in drug discovery and development, as it combines principles of organic chemistry, pharmacology, and molecular biology to create effective and safe medications. Through a thorough understanding of biological systems and chemical properties, medicinal chemists work to improve the efficacy and reduce the side effects of drugs, ensuring that they meet therapeutic needs.
New Drug Application (NDA): A New Drug Application (NDA) is a formal proposal submitted to the FDA by pharmaceutical companies seeking approval to market a new drug in the United States. This application includes comprehensive data on the drug's safety and efficacy, along with proposed labeling and manufacturing details. The NDA is a critical step following the clinical trials stage, as it transitions a drug from development into the market, directly connecting with regulatory processes and international standards.
Pharmaceutical companies: Pharmaceutical companies are businesses that research, develop, manufacture, and market drugs and medications for human and animal health. They play a vital role in the healthcare ecosystem by bringing innovative therapies to market, which often involves complex processes including regulatory compliance and extensive clinical trials.
Pharmacodynamics: Pharmacodynamics is the branch of pharmacology that studies the effects of drugs on the body and how they exert their therapeutic effects. This includes understanding the mechanisms of action, the relationship between drug concentration and effect, and how drugs interact with cellular receptors. It plays a crucial role in determining the appropriate dosages and therapeutic windows during the various stages of drug discovery and development.
Pharmacokinetics: Pharmacokinetics is the branch of pharmacology that studies how the body absorbs, distributes, metabolizes, and excretes drugs. This process is crucial for understanding the time course of drug action and helps to determine appropriate dosing regimens, safety, and efficacy during the stages of drug discovery and development. It involves evaluating the movement of drugs through the body and how various factors influence their therapeutic outcomes.
Phase I Trials: Phase I trials are the first stage of clinical testing for new drugs or treatments, primarily focused on assessing their safety, tolerability, and pharmacokinetics in a small group of healthy volunteers or patients. This phase is crucial as it lays the groundwork for understanding how a drug behaves in the body and helps identify any potential side effects before moving on to larger trials.
Phase II Trials: Phase II trials are a crucial stage in the clinical development of new drugs, designed to assess the efficacy and safety of a drug in a larger group of patients who have the condition the drug aims to treat. These trials typically involve several hundred participants and aim to determine the optimal dosage and further evaluate the drug's effectiveness, often through randomized controlled trials. This stage bridges the gap between initial safety assessments conducted in Phase I trials and more extensive efficacy studies planned for Phase III trials.
Phase III Trials: Phase III trials are large-scale clinical studies conducted to assess the effectiveness, safety, and side effects of a new drug or treatment compared to standard therapies or placebos. These trials typically involve thousands of participants across multiple locations and are crucial in determining whether a drug should be submitted for regulatory approval, linking them closely to the stages of drug discovery and development as well as measuring R&D productivity and return on investment.
Post-Approval Studies: Post-approval studies are research activities mandated by regulatory authorities to evaluate the ongoing safety and effectiveness of a drug or medical device after it has received market approval. These studies help gather more comprehensive data about the product's performance in real-world settings and assess any long-term effects or rare adverse events that may not have been evident during pre-approval clinical trials. They play a crucial role in maintaining product safety and ensuring that the benefits of the treatment continue to outweigh any risks.
Post-Marketing Surveillance: Post-marketing surveillance refers to the processes and activities that monitor the safety and effectiveness of pharmaceutical products after they have been approved for public use. This phase is critical as it allows for the identification of any rare or long-term side effects that were not evident during clinical trials, ensuring ongoing patient safety and product efficacy. The importance of post-marketing surveillance lies in its ability to provide real-world data about a drug's performance, which can influence future regulatory decisions and manufacturing practices.
Randomized controlled trial: A randomized controlled trial (RCT) is a scientific study design that randomly assigns participants into an experimental group or a control group to measure the effect of an intervention, typically a new drug or treatment. This method minimizes bias and allows for a clearer comparison of outcomes, providing high-quality evidence on the efficacy and safety of medical interventions. RCTs are crucial in the later stages of drug development, where they are used to test how effective and safe a drug is in larger, more diverse populations.
Regulatory Agencies: Regulatory agencies are governmental bodies responsible for overseeing and enforcing laws and regulations within specific industries, including the pharmaceutical, biotechnology, and medical device sectors. They ensure that products are safe, effective, and manufactured according to established standards throughout the drug discovery and development process. Their role is crucial in protecting public health and maintaining ethical practices in research and product approval.
Research Institutions: Research institutions are organizations dedicated to advancing knowledge through systematic investigation and experimentation, particularly in fields like pharmaceuticals, biotechnology, and medical devices. These institutions play a crucial role in the early stages of drug discovery and development by conducting essential research that leads to the identification of potential drug candidates and their mechanisms of action. They often collaborate with universities, government entities, and private industry to facilitate innovation and translate research findings into practical applications.
Return on Investment (ROI): Return on Investment (ROI) is a financial metric used to evaluate the efficiency of an investment by comparing the gain or loss generated relative to the cost of that investment. Understanding ROI is crucial for making informed decisions in various areas, such as drug development, funding strategies, and market launches, as it helps stakeholders assess the potential profitability and effectiveness of their investments in the pharmaceutical and medical device industries.
Risk Evaluation and Mitigation Strategies (REMS): Risk Evaluation and Mitigation Strategies (REMS) are a set of safety measures put in place by the FDA to manage known or potential risks associated with certain medications. REMS aim to ensure that the benefits of a drug outweigh its risks, particularly for products that have significant safety concerns. By providing a framework for communication and risk management, REMS play a crucial role in the stages of drug discovery and development, as well as in post-market surveillance and safety monitoring.
Structure-activity relationship (SAR): Structure-activity relationship (SAR) refers to the relationship between the chemical structure of a molecule and its biological activity. Understanding SAR is crucial during drug discovery and development because it helps researchers identify which molecular features are responsible for a compound's effectiveness and how modifications can enhance or reduce its therapeutic effects.
Target Identification: Target identification is the process of discovering and validating specific biological molecules or pathways that can be modulated by a drug to achieve a therapeutic effect. This stage is crucial in drug discovery because it helps to define the objectives for drug development and sets the direction for subsequent research activities, including lead compound discovery and optimization.
Toxicology Studies: Toxicology studies are scientific assessments that evaluate the adverse effects of substances, particularly drugs, on biological systems. These studies play a critical role in drug discovery and development by ensuring that potential therapies are safe for human use, identifying toxic doses, and understanding mechanisms of toxicity. By providing vital data on how compounds interact with living organisms, toxicology studies inform regulatory decisions and help in the design of safer drugs.